Currently out of the existing stock ratings of Emily Bodnar, 173 are a BUY (83.57%), 34 are a HOLD (16.43%).

Emily Bodnar

Work Performance Price Targets & Ratings Chart

Analyst Emily Bodnar, carries an average stock price target met ratio of 28.01% that have a potential upside of 51.72% achieved within 84 days. Previously, Emily Bodnar worked at HC WAINWRIGHT.

Emily Bodnar’s has documented 378 price targets and ratings displayed on 23 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on FEMY, Femasys at 28-Mar-2025.

Wall Street Analyst Emily Bodnar

Analyst best performing recommendations are on BCTX (BRIACELL THERAPEUTICS CORP).
The best stock recommendation documented was for NVCR (NOVOCURE LTD) at 11/21/2024. The price target of $30 was fulfilled within 12 days with a profit of $12.91 (75.54%) receiving and performance score of 62.95.

Average potential price target upside

DICE Dice Molecules Holdings LLC FEMY Femasys NVCR Novocure Ltd OLMA Olema Pharmaceuticals VTYX Ventyx Biosciences SQZ Sqz Biotechnologies Co ACLX Arcellx BCTX Briacell Therapeutics Corp CNTX Context Therapeutics GRCL Gracell Biotechnologies INKT Mink Therapeutics IOBT IO Biotech NKTX Nkarta  RNAZ Transcode Therapeutics AGEN Agenus SANA Sana Biotechnology JSPR Jasper Therapeutics ANAB AnaptysBio RCUS Arcus Biosciences GERN Geron NXTC NextCure  ATOS Atossa Genetics CNTB Connect Biopharma Holdings Ltd

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$48

$0.45 (0.95%)

$48

1 years 7 months 27 days ago
(09-Aug-2023)

1/8 (12.5%)

$0.45 (0.95%)

85

Hold

$56

1 years 9 months 10 days ago
(26-Jun-2023)

0/1 (0%)

$27.35 (95.46%)

Hold

$48

$0.45 (0.95%)

$68

1 years 9 months 16 days ago
(20-Jun-2023)

1/3 (33.33%)

$1.56 (3.36%)

27

Hold

$48

$0.45 (0.95%)

$38

1 years 9 months 16 days ago
(20-Jun-2023)

1/2 (50%)

$1.56 (3.36%)

27

Hold

$48

$0.45 (0.95%)

$71

1 years 9 months 16 days ago
(20-Jun-2023)

0/2 (0%)

$1.56 (3.36%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Emily Bodnar is most bullish on?

Potential upside of $56.41 has been obtained for ACLX (ARCELLX)

Which stock is Emily Bodnar is most reserved on?

Potential downside of -$0 has been obtained for VTYX (VENTYX BIOSCIENCES)

What Year was the first public recommendation made by Emily Bodnar?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?